What stocks does Mirae Asset Healthcare Fund Direct Growth hold?

Mirae Asset Healthcare Fund Direct Growth holds a portfolio of Indian equity stocks disclosed monthly by Mirae Asset Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Mirae Asset Healthcare Fund Direct Growth?

Mirae Asset Healthcare Fund Direct Growth is managed by Mirae Asset Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Mirae Asset Healthcare Fund Direct Growth?

Mirae Asset Healthcare Fund Direct Growth is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is Mirae Asset Healthcare Fund Direct Growth portfolio data updated?

Portfolio holdings for Mirae Asset Healthcare Fund Direct Growth are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Mirae Asset Mutual Fund

Mirae Asset Healthcare Fund Direct Growth

Equity Data as of Sep 2026 Comparing Jul 2026 → Sep 2026

Share: WhatsApp X

⌕

Stocks Held

Sep 2026

Equity Holdings

₹3,493.48 Cr

Equity only, excl. debt & cash

AAUM

₹3,414.29 Cr

Jul-Sep 2026 · Direct + Regular

Top 5 Weight

37.9%

Moderate

Top 10 Weight

58.4%

Moderate

Changes

2 new · 0 exits

Top Sector

Pharmaceuticals & Biotechnology

75.8% of portfolio

Launch Date

11 Jun 2018

8 years old

AAUM (Average Assets Under Management) of ₹3,414.29 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month Mirae Asset Healthcare Fund Direct Growth added 2 new stocks to its portfolio this month. The biggest new buy was Molbio Diagnostics Ltd. (Healthcare Equipment & Supplies) at 1.77% weight. Among existing holdings, Dr. Reddy's Laboratories Limited saw the biggest increase — now at 4.84% of the portfolio. Narayana Hrudayalaya Limited was trimmed the most, now at 0.00%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 75.8%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Mirae Asset Healthcare Fund Direct Growth

-2.35%

+0.47%

+14.58%

+16.08%

Latest NAV

₹50.43

13 Oct 2026

52W High

₹53.13

-5% from High

52W Low

₹39.65

+27% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.0%

2024

+41.2%

2023

+36.1%

2022

-10.5%

2021

+28.6%

2020

+76.8%

2019

+8.1%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

25.7%

+ve in 82% windows

92.0% / -10.5%

3Y Rolling Avg

24.2% p.a.

+ve in 100% windows

36.4% / 13.3%

5Y Rolling Avg

24.1% p.a.

+ve in 100% windows

34.1% / 15.8%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-15.9%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-20.0%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-17.4%

Rec: Jun 2023 (1yr 6mo)

2018 IL&FS

-10.9%

Rec: Jan 2020 (1yr 9mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. · CAGR, Sharpe Ratio & Standard Deviation — Mutual Fund Guide →

Sharpe Ratio (3Y)

1.24

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

1.81

Penalises downside volatility only.

Std Deviation (3Y)

14.0%

Lower = more consistent returns.

NAV Chart ₹50.43 13 Oct 2026

Simple Moving Avg: Click to draw · click again to remove

Mirae Asset Healthcare Fund Direct Growth

Chart shows indexed performance (base = 100). Actual NAV: ₹50.43

Sector Shift Industry allocation month-over-month

Jun 2026 → Jul 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	74.9%	74.8%	▼ -0.2%
Healthcare Services	23.8%	22.9%	▼ -0.8%
Chemicals & Petrochemicals	1.1%	1.1%	● 0.0%

Jul 2026 → Sep 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	74.8%	75.8%	▲ +1.0%
Healthcare Services	22.9%	20.5%	▼ -2.4%
Chemicals & Petrochemicals	1.1%	1.9%	▲ +0.9%
Healthcare Equipment & Supplies	0.0%	1.8%	▲ +1.8%

🟢

Biggest New Buy

Molbio Diagnostics Ltd.

1.77% weight · Healthcare Equipment & Supplies

↑

Biggest Add

Dr. Reddy's Laboratories Limited

+1.38% · now 4.84%

↓

Biggest Trim

Narayana Hrudayalaya Limited

-1.19% · now 0.00%

🤝 Other funds also bought this month

Symbiotec Pharmalab Limited 31 funds

Molbio Diagnostics Ltd. 26 funds

What Changed in the Portfolio This Month?

Comparing Jul 2026 → Sep 2026

Jul 2026 → Sep 2026

🟢 2 New Entries ↑ 11 Increased ↓ 16 Decreased

#	Stock	Sector	Weight (Sep 2026)
1	Molbio Diagnostics Ltd. ₹61.89 Cr	Healthcare Equipment & Supplies	1.77%
2	Symbiotec Pharmalab Limited ₹55.81 Cr	Pharmaceuticals & Biotechnology	1.60%

#	Stock	Sector	Jul 2026	Sep 2026	Change
1	Dr. Reddy's Laboratories Limited ₹169.12 Cr	Pharmaceuticals & Biotechnology	3.46%	4.84%	+1.38%
2	Divi's Laboratories Limited ₹342.10 Cr	Pharmaceuticals & Biotechnology	8.71%	9.79%	+1.08%
3	Neogen Chemicals Limited ₹52.53 Cr	Chemicals & Petrochemicals	0.61%	1.50%	+0.89%
4	Gland Pharma Limited ₹93.92 Cr	Pharmaceuticals & Biotechnology	2.11%	2.69%	+0.58%
5	Laurus Labs Limited ₹192.60 Cr	Pharmaceuticals & Biotechnology	5.13%	5.51%	+0.38%
6	IPCA Laboratories Limited ₹118.45 Cr	Pharmaceuticals & Biotechnology	3.13%	3.39%	+0.26%
7	Alkem Laboratories Limited ₹131.36 Cr	Pharmaceuticals & Biotechnology	3.56%	3.76%	+0.20%
8	Mankind Pharma Limited ₹78.35 Cr	Pharmaceuticals & Biotechnology	2.04%	2.24%	+0.20%
9	Aster DM Healthcare Limited ₹116.18 Cr	Healthcare Services	3.14%	3.32%	+0.18%
10	Dr. Lal Path Labs Limited ₹101.33 Cr	Healthcare Services	2.81%	2.90%	+0.09%
11	Sai Life Sciences Limited ₹112.79 Cr	Pharmaceuticals & Biotechnology	3.17%	3.23%	+0.06%

#	Stock	Sector	Jul 2026	Sep 2026	Change
1	Narayana Hrudayalaya Limited ₹3.56 L	Healthcare Services	1.19%	0.00%	-1.19%
2	Lupin Limited ₹79.21 Cr	Pharmaceuticals & Biotechnology	3.27%	2.27%	-1.00%
3	Sun Pharmaceutical Industries Limited ₹354.62 Cr	Pharmaceuticals & Biotechnology	11.06%	10.15%	-0.91%
4	Glenmark Pharmaceuticals Limited ₹166.96 Cr	Pharmaceuticals & Biotechnology	5.53%	4.78%	-0.75%
5	Torrent Pharmaceuticals Limited ₹237.70 Cr	Pharmaceuticals & Biotechnology	7.47%	6.80%	-0.67%
6	Fortis Healthcare Limited ₹102.65 Cr	Healthcare Services	3.55%	2.94%	-0.61%
7	Max Healthcare Institute Limited ₹81.96 Cr	Healthcare Services	2.81%	2.35%	-0.46%
8	Eris Lifesciences Limited ₹83.38 Cr	Pharmaceuticals & Biotechnology	2.82%	2.39%	-0.43%
9	Cipla Limited ₹92.01 Cr	Pharmaceuticals & Biotechnology	3.03%	2.63%	-0.40%
10	Apollo Hospitals Enterprise Limited ₹196.34 Cr	Healthcare Services	5.94%	5.62%	-0.32%
11	Onesource Specialty Pharma Limited ₹105.27 Cr	Pharmaceuticals & Biotechnology	3.23%	3.01%	-0.22%
12	Anthem Biosciences Limited ₹32.45 Cr	Pharmaceuticals & Biotechnology	1.15%	0.93%	-0.22%
13	Krishna Institute Of Medical Sciences Limited ₹118.43 Cr	Healthcare Services	3.48%	3.39%	-0.09%
14	Biocon Limited ₹70.05 Cr	Pharmaceuticals & Biotechnology	2.08%	2.00%	-0.08%
15	Aurobindo Pharma Limited ₹131.98 Cr	Pharmaceuticals & Biotechnology	3.82%	3.78%	-0.04%
16	Deepak Nitrite Limited ₹14.00 Cr	Chemicals & Petrochemicals	0.44%	0.40%	-0.04%

What Stocks Does This Fund Hold?

29 stocks — Sep 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹354.62 Cr	Pharmaceuticals & Biotechnology	10.15%
2	Divi's Laboratories Limited ₹342.10 Cr	Pharmaceuticals & Biotechnology	9.79%
3	Torrent Pharmaceuticals Limited ₹237.70 Cr	Pharmaceuticals & Biotechnology	6.80%
4	Apollo Hospitals Enterprise Limited ₹196.34 Cr	Healthcare Services	5.62%
5	Laurus Labs Limited ₹192.60 Cr	Pharmaceuticals & Biotechnology	5.51%
6	Dr. Reddy's Laboratories Limited ₹169.12 Cr	Pharmaceuticals & Biotechnology	4.84%
7	Glenmark Pharmaceuticals Limited ₹166.96 Cr	Pharmaceuticals & Biotechnology	4.78%
8	Aurobindo Pharma Limited ₹131.98 Cr	Pharmaceuticals & Biotechnology	3.78%
9	Alkem Laboratories Limited ₹131.36 Cr	Pharmaceuticals & Biotechnology	3.76%
10	Krishna Institute Of Medical Sciences Limited ₹118.43 Cr	Healthcare Services	3.39%
11	IPCA Laboratories Limited ₹118.45 Cr	Pharmaceuticals & Biotechnology	3.39%
12	Aster DM Healthcare Limited ₹116.18 Cr	Healthcare Services	3.32%
13	Sai Life Sciences Limited ₹112.79 Cr	Pharmaceuticals & Biotechnology	3.23%
14	Onesource Specialty Pharma Limited ₹105.27 Cr	Pharmaceuticals & Biotechnology	3.01%
15	Fortis Healthcare Limited ₹102.65 Cr	Healthcare Services	2.94%
16	Dr. Lal Path Labs Limited ₹101.33 Cr	Healthcare Services	2.90%
17	Gland Pharma Limited ₹93.92 Cr	Pharmaceuticals & Biotechnology	2.69%
18	Cipla Limited ₹92.01 Cr	Pharmaceuticals & Biotechnology	2.63%
19	Eris Lifesciences Limited ₹83.38 Cr	Pharmaceuticals & Biotechnology	2.39%
20	Max Healthcare Institute Limited ₹81.96 Cr	Healthcare Services	2.35%
21	Lupin Limited ₹79.21 Cr	Pharmaceuticals & Biotechnology	2.27%
22	Mankind Pharma Limited ₹78.35 Cr	Pharmaceuticals & Biotechnology	2.24%
23	Biocon Limited ₹70.05 Cr	Pharmaceuticals & Biotechnology	2.00%
24	Molbio Diagnostics Ltd. ₹61.89 Cr	Healthcare Equipment & Supplies	1.77%
25	Symbiotec Pharmalab Limited ₹55.81 Cr	Pharmaceuticals & Biotechnology	1.60%
26	Neogen Chemicals Limited ₹52.53 Cr	Chemicals & Petrochemicals	1.50%
27	Anthem Biosciences Limited ₹32.45 Cr	Pharmaceuticals & Biotechnology	0.93%
28	Deepak Nitrite Limited ₹14.00 Cr	Chemicals & Petrochemicals	0.40%
29	Narayana Hrudayalaya Limited ₹3.56 L	Healthcare Services	0.00%